Angelic Acid Prevents RANKL-Induced Osteoclastogenesis Through Pathway-Biased Inhibition of MAPK–NFATc1 Signaling
. These findings identify AA as a novel inhibitor of the RANKL-MAPK-NFATc1 axis, providing a mechanistic foundation for its therapeutic development in osteoporosis and other osteolytic diseases.
Authors
- Mojtaba Tabandeh (ORCID: https://orcid.org/0000-0002-2158-2631)
- Vishwa Deepak (ORCID: https://orcid.org/0000-0003-0268-8411)
- Lifang Zhang
Institutions
- Wenzhou-Kean University (CN)
- Kean University (US)
Publication Details
- Journal
- Current Issues in Molecular Biology
- Published
- 2026-04-17
- DOI
- https://doi.org/10.3390/cimb48040412
- Primary Topic
- Bone Metabolism and Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00